What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Radiation therapy
His primary areas of study are Nuclear medicine, Positron emission tomography, Radiology, Radiation therapy and Lesion.
His research integrates issues of Tomography and Lung in his study of Nuclear medicine.
His Positron emission tomography study combines topics in areas such as Medical imaging, Misonidazole, 18F-Fluoromisonidazole, FMISO and Magnetic resonance imaging.
His research in Radiology intersects with topics in Carcinoma and Reproducibility.
In his research, Colorectal cancer, Prospective cohort study and Rectum is intimately related to Positron emission, which falls under the overarching field of Radiation therapy.
His work deals with themes such as Concordance, Tumor glycolysis and Total lesion glycolysis, which intersect with Lesion.
His most cited work include:
- Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study. (877 citations)
- Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. (775 citations)
- Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis. (460 citations)
What are the main themes of his work throughout his whole career to date?
John L. Humm mostly deals with Nuclear medicine, Positron emission tomography, Radiology, Pathology and Radiation therapy.
John L. Humm combines subjects such as Lesion and Medical imaging with his study of Nuclear medicine.
John L. Humm studied Positron emission tomography and Tumor hypoxia that intersect with Misonidazole.
His work in Head and neck cancer and Radiation treatment planning are all subfields of Radiology research.
His Pathology study integrates concerns from other disciplines, such as Hypoxia and Antibody, Monoclonal antibody.
His work is dedicated to discovering how Dosimetry, Radioimmunotherapy are connected with Pharmacokinetics, Cancer research, Cerebrospinal fluid and Therapeutic index and other disciplines.
He most often published in these fields:
- Nuclear medicine (53.53%)
- Positron emission tomography (24.41%)
- Radiology (16.47%)
What were the highlights of his more recent work (between 2017-2021)?
- Nuclear medicine (53.53%)
- Internal medicine (10.88%)
- Cancer research (9.71%)
In recent papers he was focusing on the following fields of study:
John L. Humm mainly focuses on Nuclear medicine, Internal medicine, Cancer research, Oncology and Radioimmunotherapy.
The various areas that John L. Humm examines in his Nuclear medicine study include Pharmacokinetics, Hypoxia, Repeatability, Biopsy and Prostate cancer.
His Prostate cancer research includes themes of Lesion and PET-CT.
His work on Apolipoprotein E is typically connected to Cognitive decline as part of general Internal medicine study, connecting several disciplines of science.
His Radioimmunotherapy research incorporates themes from Radiology and Therapeutic index.
Within one scientific family, John L. Humm focuses on topics pertaining to Neck dissection under Radiology, and may sometimes address concerns connected to Magnetic resonance imaging.
Between 2017 and 2021, his most popular works were:
- 18F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma. (53 citations)
- Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-Fluorodeoxyglucose positron emission tomography radiomics features. (36 citations)
- Prognostic value of baseline metabolic tumor volume measured on 18 F-fluorodeoxyglucose positron emission tomography/computed tomography in melanoma patients treated with ipilimumab therapy (30 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Radiation therapy
His primary scientific interests are in Nuclear medicine, Prostate cancer, Cancer research, Biodistribution and Pharmacokinetics.
Fluorodeoxyglucose positron emission tomography is the focus of his Nuclear medicine research.
The Prostate cancer study combines topics in areas such as Immunohistochemistry, Lesion and Biopsy.
John L. Humm interconnects Cancer cell, Brain tumor and Radiation therapy in the investigation of issues within Cancer research.
The study incorporates disciplines such as Cerebrospinal fluid, Ommaya reservoir, Malignancy and Absorbed dose in addition to Biodistribution.
His Pharmacokinetics research is multidisciplinary, incorporating elements of Adipose tissue and Urology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
